Defence Therapeutics Inc. announced a non-brokered private placement of up to 1,500,000 units at a price of CAD 1.86 per unit for gross proceeds of CAD 2,790,000 on January 12, 2024. Each unit is comprising of one common share and one share purchase warrant. Each warrant will entitle the holder to acquire one additional share at a price of CAD 2.25 per share for a period of 24 months of the closing date.

The company may pay a finder's fee in connection with the offering in accordance with the policies of the CSE. The securities issued in connection with the offering will be subject to a statutory hold period of four months and one day following the closing date in accordance with the CSE.